1/15
09:45 am
ophly
Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation
Low
Report
Ono Shares Replay Information for 44th Annual J.P. Morgan Healthcare Conference Presentation
1/12
07:20 am
ophly
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/12
07:00 am
ophly
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference
1/7
05:15 am
ophly
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical [Yahoo! Finance]
Low
Report
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical [Yahoo! Finance]
12/8
10:40 pm
ophly
Has Ono Pharmaceutical's 2025 Share Price Rally Left Limited Upside? [Yahoo! Finance]
Neutral
Report
Has Ono Pharmaceutical's 2025 Share Price Rally Left Limited Upside? [Yahoo! Finance]
12/6
09:50 am
ophly
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
Low
Report
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
11/17
01:13 am
ophly
Deciphera Announces the Opening of a New Office in Zug, Switzerland [Yahoo! Finance]
Low
Report
Deciphera Announces the Opening of a New Office in Zug, Switzerland [Yahoo! Finance]
10/18
07:21 am
ophly
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025 [Yahoo! Finance]
Low
Report
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025 [Yahoo! Finance]